Literature DB >> 8866179

Biosafety in the clinical mycobacteriology laboratory.

J Y Richmond1, R C Knudsen, R C Good.   

Abstract

This article presents an expanded agent summary statement for laboratorians working with Mycobacterium tuberculosis. It focuses on reducing the serious risk of infection in clinical laboratories that process specimens from tuberculosis patients or that work with purified cultures of tubercle bacilli. Administrative and engineering controls, practices and procedures, and personal protective equipment are discussed. Guidelines for packaging specimens for transfer to another laboratory also are presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866179

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Laboratory-acquired infections: Are microbiologists at risk?

Authors:  David L Sewell
Journal:  Clin Microbiol Newsl       Date:  2005-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.